CLX vs EBS
The Clorox Company (CLX) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CLX and EBS stock pages for the full models.
Not investment advice.